Biomagnetics Completes Audit and Financial Review
02 November 2010 - 12:00AM
Business Wire
Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer
of revolutionary diagnostic systems and technology for HIV,
hepatitis, tuberculosis and malaria detection, and other innovative
technologies, today announced the completion of its full audit and
financial review, which was conducted by Seale & Beers
Certified Public Accounts, LLC.
"I am pleased that the audit has now been completed and that we
are moving toward full reporting status with the U.S. Securities
& Exchange Commission. We are excited about the future for
Biomagnetics and we want to make sure all of our investors and
shareholders have full transparency into our operations," commented
Clayton Hardman, CEO of Biomagnetics.
About Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical
device and biotechnology company and an acquirer of other
innovative technologies. More information on Biomagnetics
Diagnostics Corp. can be seen at www.biomagneticsbmgp.com.
Biomagnetics Diagnostics (CE) (USOTC:BMGP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biomagnetics Diagnostics (CE) (USOTC:BMGP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Biomagnetics Diagnostics Corp (CE) (OTCMarkets): 0 recent articles
More Biomagnetics Diagnostics Corporation News Articles